Close menu




May 7th, 2021 | 11:03 CEST

Steinhoff, wallstreet:online, Freenet - Opportunities

  • Investments
Photo credits: pixabay.com

There is always something good about a strong stock market correction. You get another chance to enter at a reasonable price. But be careful. The prerequisite is a fundamentally appropriate valuation of the target. While in some sectors, such as hydrogen or fuel cell technology is still a wide gap between the market value and the figures currently presented, there are many interesting entry opportunities in other sectors that should pay off in cash in the long term.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: NL0011375019 , DE000A2GS609 , DE000A0Z2ZZ5

Table of contents:


    Ambitious targets

    A good example of a fundamentally solid company with extremely high growth opportunities is wallstreet:online AG. The Berlin-based Company's roots is the user base it has built up over many years in the financial community via portals such as wallstreet-online.de, boersenNews.de, FinanzNachrichten.de and ARIVA.de. The four stock market portals recently achieved a combined reach of more than 455 million page impressions per month. This makes the Group by far the biggest publisher-independent financial portal operator in the German-speaking world. With the online broker Smartbroker, the transformation from user to paying customer is now to take place.

    Becoming Germany's leading broker is the declared goal of the new CEO of wallstreet:online AG, Matthias Hach. Since the product launch in December 2019, more than 130,000 customers have already been acquired. The number is expected to grow to at least 200,000 by the end of the current year. The former Comdirect board member sees the recipe for success in the connection of the two products. In addition to a smartphone app, there will be a stronger linking of broker features on the in-house community pages.

    Merging at all levels: In addition to the technical merger of the community with the broker, the Company also recently announced an increase in its stake in wallstreet:online capital AG by 19.3%. Following the successful transaction, the Company's total stake in wallstreet:online capital AG will exceed the 95% threshold. In the coming months, the management also intends to further expand this stake in the Smartbroker's operating company. The aim is to leverage financial synergies and simplify the organizational structure. The long-standing wallstreet:online capital AG board member and founding CEO of the broker, Thomas Soltau, who successfully launched the Company on the market, is also to remain on board and continue to help shape the growth course the Company has embarked upon.

    The wallstreet:online share could not escape the current market correction. After reaching an all-time high in mid-February, the stock is currently trading at EUR 21.60 after bottoming out in the EUR 18.50 range. Even if this support can be tested again in the short term, the prospects for higher prices in the long term are more than given. This opinion is also shared by individual Supervisory Board members of the Group, who already made purchases in the area around the EUR 23 mark at the end of last month.

    Steinhoff - Things are getting more concrete

    It may not be the solution to all problems for Steinhoff International, which is suffering from high debts and accounting scandals, but it is at least a ray of hope: The Company used last week's virtual Annual General Meeting to philosophize about a possible IPO of the Dutch subsidiary Pepco at the end of April. Now the planned initial listing is scheduled for May 26 on the Warsaw Stock Exchange.

    If you want to call your bank advisor, forget about it. Only private investors from Poland and institutional investors can buy. The Warsaw stock exchange was chosen for strategic reasons. Pepco operates more than 3,200 stores in 16 countries, though more than 1,000 in Poland alone.
    The offering comprises around 101 million shares, most of which come from Steinhoff, representing a good 17.5% of the Company's shares. In addition, there is an option to place just under 15 million further shares. The price range for the Pepco shares is said to be between EUR 8.35 and EUR 10.11, which in the best case would provide the parent company with gross proceeds of more than EUR 1 billion.

    Freenet at a decisive point

    After the reported quarterly figures, Freenet's share price reacted positively with a plus of almost 5% and pushed up to the important resistance at EUR 21.50. If the share price rises significantly above this level it will continue to be a sell candidate. If the share price significantly surpasses this level, it could now turn its attention to the EUR 28 mark. The figures for the first quarter were somewhat mixed. In the first three months of the year, Freenet generated revenues of EUR 619.2 million, a good 4.6% less than in the same period of the previous year, but profitability increased. EBITDA was up 4.4% year-on-year. The main reason for the higher profits was, among other things, the streaming service waipu.tv.

    The Executive Board expects a stable revenue development and an EBITDA between EUR 415 and 435 million for the full year. Following the figures, analysts at Warburg Research left their rating for Freenet at "buy" with a price target of EUR 24, while the experts at Goldman Sachs continue to see Freenet shares as a "sell" candidate with a price target of EUR 16.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read